CDK8 and colonic neoplasm: Furthermore, we used the clinical data of TCGA to show that the colon cancer patients with CDK8 amplification were diagnosed with more lymph node spread (p = 0.006, proportion test, Supplementary Fig. 6f) and have significantly shorter DFS (p = 0.003, log-rank test, Fig. 5i).